Abpro Holdings Inc. (ABPO) vs Silexion Therapeutics Corp (SLXN)

Abpro Holdings Inc. and Silexion Therapeutics Corp are both Biotechnology companies. Abpro Holdings Inc. and Silexion Therapeutics Corp are of similar size ($1.4M and $1.4M). Silexion Therapeutics Corp has negative trailing earnings, so its P/E is not meaningful; Abpro Holdings Inc. trades at 0.2×. Across the 8 metrics below, Abpro Holdings Inc. leads on 5 and Silexion Therapeutics Corp on 3.

Valuation

Metric ABPO SLXN Biotechnology median
P/E 0.20 n/m 7.88
P/S n/m n/m 11.47
P/B n/m 4.06 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.41 0.04 0.74
EV/Sales n/m n/m 10.73
Earnings yield 500.00% (8,359.54%) (28.84%)
Free cash flow yield (311.42%) (6,963.95%) (23.03%)

Profitability

Metric ABPO SLXN Biotechnology median
Gross margin — — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (20.18%) (17,021.95%) (57.72%)
Return on assets 46.10% (277.96%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ABPO SLXN Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 94.15% 97.73% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABPO SLXN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.62 0.94 4.73
Net debt to EBITDA 0.01 0.38 0.96

Dividend

Metric ABPO SLXN Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ABPO SLXN Biotechnology median
Market cap 1.42m 1.44m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack